inhibitor

One idea is to locate binding sites on the DNAJB1 protein to which a drug inhibitor could bind.

Abrocitinib is a JAK1 inhibitor drug that works to suppress inflammation, specifically pro-inflammatory chemicals called cytokines that are involved in an overactive immune system.

However, treatment with an enzyme inhibitor that prevents the activation of lipids can restore balance and alleviate symptoms.

However, this mechanism can be rebalanced by treatment with an inhibitor that prevents the activation of these lipids in the brain.

Pembrolizumab, a well-known PD-1 inhibitor, further enhances the immune system's ability to attack cancer cells.